Jayson Bedford
Stock Analyst at Raymond James
(3.79)
# 601
Out of 5,182 analysts
323
Total ratings
53.72%
Success rate
6.9%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Downgrades: Outperform | $97 → $88 | $60.99 | +44.29% | 27 | Mar 30, 2026 | |
| MASI Masimo | Downgrades: Market Perform | n/a | $178.45 | - | 8 | Mar 27, 2026 | |
| TFX Teleflex | Upgrades: Outperform | $128 | $131.95 | -2.99% | 13 | Mar 27, 2026 | |
| AXGN Axogen | Maintains: Outperform | $20 → $27 | $37.23 | -27.48% | 2 | Oct 30, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $592 → $603 | $465.60 | +29.51% | 9 | Oct 22, 2025 | |
| CBLL CeriBell | Initiates: Strong Buy | $19 | $21.11 | -10.00% | 1 | Oct 21, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $141 → $146 | $96.00 | +52.08% | 30 | Oct 16, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $174 → $209 | $230.69 | -9.40% | 24 | Oct 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $104 → $113 | $95.48 | +18.35% | 9 | Aug 8, 2025 | |
| ICUI ICU Medical | Maintains: Strong Buy | $187 → $180 | $130.62 | +37.80% | 22 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $108 → $102 | $69.79 | +46.15% | 28 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $99 → $102 | $64.62 | +57.85% | 31 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $328 → $360 | $200.87 | +79.22% | 27 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $270 | $158.64 | +70.20% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $10.79 | -7.32% | 14 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $15.68 | - | 10 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.24 | - | 13 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $81.44 | - | 20 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $18.84 | - | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $85.00 | - | 14 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $6.87 | - | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.92 | - | 5 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $11.16 | - | 3 | Jan 2, 2018 |
Boston Scientific
Mar 30, 2026
Downgrades: Outperform
Price Target: $97 → $88
Current: $60.99
Upside: +44.29%
Masimo
Mar 27, 2026
Downgrades: Market Perform
Price Target: n/a
Current: $178.45
Upside: -
Teleflex
Mar 27, 2026
Upgrades: Outperform
Price Target: $128
Current: $131.95
Upside: -2.99%
Axogen
Oct 30, 2025
Maintains: Outperform
Price Target: $20 → $27
Current: $37.23
Upside: -27.48%
Intuitive Surgical
Oct 22, 2025
Maintains: Outperform
Price Target: $592 → $603
Current: $465.60
Upside: +29.51%
CeriBell
Oct 21, 2025
Initiates: Strong Buy
Price Target: $19
Current: $21.11
Upside: -10.00%
Abbott Laboratories
Oct 16, 2025
Maintains: Outperform
Price Target: $141 → $146
Current: $96.00
Upside: +52.08%
Johnson & Johnson
Oct 15, 2025
Maintains: Outperform
Price Target: $174 → $209
Current: $230.69
Upside: -9.40%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $104 → $113
Current: $95.48
Upside: +18.35%
ICU Medical
Aug 8, 2025
Maintains: Strong Buy
Price Target: $187 → $180
Current: $130.62
Upside: +37.80%
Jul 31, 2025
Maintains: Outperform
Price Target: $108 → $102
Current: $69.79
Upside: +46.15%
Jul 31, 2025
Maintains: Strong Buy
Price Target: $99 → $102
Current: $64.62
Upside: +57.85%
May 27, 2025
Maintains: Outperform
Price Target: $328 → $360
Current: $200.87
Upside: +79.22%
Aug 2, 2024
Maintains: Outperform
Price Target: $275 → $270
Current: $158.64
Upside: +70.20%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $10.79
Upside: -7.32%
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $15.68
Upside: -
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $21.24
Upside: -
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $81.44
Upside: -
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $18.84
Upside: -
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $85.00
Upside: -
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $6.87
Upside: -
Aug 2, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $0.92
Upside: -
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $11.16
Upside: -